Peter Greenleaf - 02 Mar 2023 Form 4/A Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Executive Officer, Director
Signature: /s/ Peter S. Greenleaf
Issuer symbol: AUPH
Transactions as of: 02 Mar 2023
Transactions value $: -$290,153
Form type: 4/A
Filing time: 22 Feb 2024, 16:15:26
Date Of Original Report: 06 Mar 2023
Previous filing: 26 May 2022
Next filing: 22 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Sale	-$290K	-33K	-3.25%	$8.78	983K	02 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.

Remarks:

This amendment is being filed to amend the Form 4 filed on March 6, 2023 with the SEC in order to correct the amount sold, price per share and total securities owned after the transaction.